FIELD: chemistry.
SUBSTANCE: invention relates to individual compounds comprising 4-hydroxy-1,2,3,4-tetrahydronaphthalene-1-yl-urea, and pharmaceutically acceptable salts thereof. Compounds of invention have properties of inhibitor of p38 MAP kinase. Invention also relates to pharmaceutical composition, to method for inhibiting p38 MAP kinase and to use of compounds in manufacture of medicament.
EFFECT: Technical result provided new compounds having properties of inhibitor of p38 MAP kinase, which are useful as anti-inflammatory agents in treatment of diseases of respiratory tract.
9 cl, 3 tbl, 34 ex
| Title | Year | Author | Number |
|---|---|---|---|
| KINASE INHIBITORS | 2012 |
|
RU2623734C9 |
| KINASE INHIBITORS | 2013 |
|
RU2637944C2 |
| UREA DERIVATIVES AND THERAPEUTIC USE THEREOF IN TREATING, AMONG OTHER THINGS, RESPIRATORY TRACT DISEASES | 2011 |
|
RU2586223C2 |
| HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
| CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
| AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
| BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
| mTOR KINASE INHIBITORS FOR ONCOLOGICAL INDICATIONS AND DISEASES METABOLICALLY BOUND TO mTOR/PI3K/AKT | 2009 |
|
RU2546658C2 |
| BICYCLIC KETONES AND METHODS OF THEIR USE | 2018 |
|
RU2797922C2 |
| COMPOUNDS OF PYRIDAZINAMIDE AND THEIR USE AS SYNTHETIC SYNECKINASIS INHIBITORS (SYK) | 2013 |
|
RU2627661C2 |
